Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.410
+0.090 (6.82%)
Jun 24, 2025, 12:41 PM - Market open
Caribou Biosciences Revenue
Caribou Biosciences had revenue of $2.35M in the quarter ending March 31, 2025, a decrease of -3.13%. This brings the company's revenue in the last twelve months to $9.92M, down -70.31% year-over-year. In the year 2024, Caribou Biosciences had annual revenue of $9.99M, down -71.01%.
Revenue (ttm)
$9.92M
Revenue Growth
-70.31%
P/S Ratio
12.13
Revenue / Employee
$67,469
Employees
147
Market Cap
131.14M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CRBU News
- 26 days ago - Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference - GlobeNewsWire
- 2 months ago - Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 2 months ago - Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire